US 11311485
Self-assembled particles for targeted delivery of immunomodulators to treat autoimmunity and cancer
granted A61KA61K31/4706A61K31/52
Quick answer
US patent 11311485 (Self-assembled particles for targeted delivery of immunomodulators to treat autoimmunity and cancer) held by Northwestern University expires Mon Apr 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Northwestern University
- Grant date
- Tue Apr 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/4706, A61K31/52, A61K31/573, A61K9/1075